2010Practical Journal of Medicine & PharmacyRequires access

Olanzapine(note-min) and clozapine in the treatment of refractory schizophrenia:A contrast study

Zhang We

Open publisher page 0 citations

Abstract

Objective To investigate the efficacy and safety of olanzapine(note-min) in the treatment of refractory schizophrenia.Methods The 65 patients with refractory schizophrenia were randomly divided into two groups(study group:34 patients,the control group:31 cases);and respectively subjected to olanzapine(note-min) in study group,and clozapine treatment in coutrol group;treatment for 12 weeks;Positive Symptoms and Negative Symptoms Scale(PANSS) assessment of efficacy,adverse reactions with the scale(TESS) assessment of adverse reactions were made.Results Olanzapine(note-min) in the treatment response rate was 47.1%,clozapine 45.2%,overall efficacy difference between the two groups was not statistically significant(P0.05);olanzapine(note-min) in adverse response was low and mild.Conclusion The therapeutic effect of olanzapine(note-min) in the treatment of refractory schizophrenia is considerable as clozapine,and of high security.

About this research paper

What this paper is about

Objective To investigate the efficacy and safety of olanzapine(note-min) in the treatment of refractory schizophrenia.Methods The 65 patients with refractory schizophrenia were randomly divided into two groups(study group:34 patients,the control group:31 cases);and respectively subjected to olanzapine(note-min) in study group,and clozapine treatment in coutrol group;treatment for 12 weeks;Positive Symptoms and Negative Symptoms Scale(PANSS) assessment of efficacy,adverse reactions with the scale(TESS) assessment of adverse reactions were made.Results Olanzapine(note-min) in the treatment response rate was 47.1%,clozapine 45.2%,overall efficacy difference between the two groups was not statistically significant(P0.05);olanzapine(note-min) in adverse response was low and mild.Conclusion The therapeutic effect of olanzapine(note-min) in the treatment of refractory schizophrenia is considerable as clozapine,and of high security.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the efficacy and safety of olanzapine(note-min) in the treatment of refractory schizophrenia.Methods The 65 patients with refractory schizophrenia were randomly divided into two groups(study group:34 patients,the control group:31 cases);and respectively subjected to olanzapine(note-min) in study group,and clozapine treatment in coutrol group;treatment for 12 weeks;Positive Symptoms and Negative Symptoms Scale(PANSS) assessment of efficacy,adverse reactions with the scale(TESS) assessment of adverse reactions were made.Results Olanzapine(note-min) in the treatment response rate was 47.1%,clozapine 45.2%,overall efficacy difference between the two groups was not statistically significant(P0.05);olanzapine(note-min) in adverse response was low and mild.Conclusion The therapeutic effect of olanzapine(note-min) in the treatment of refractory schizophrenia is considerable as clozapine,and of high security.

Key concepts: Olanzapine, Clozapine, Refractory (planetary science), Schizophrenia (object-oriented programming), Adverse effect, Medicine, Internal medicine, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Olanzapine(note-min) and clozapine in the treatment of refractory schizophrenia:A contrast study — Research Paper | ScholarLens